Apr 29, 2024, 07:58
Rahul Gosain: FDA approval of Fruquintinib from FRESCO2 and how it fits in our Rx paradigm with N. Arvind Dasari
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, recently shared on LinkedIn:
“GISeries: In this episode, we get a chance to discuss FDA approval of Fruquintinib from FRESCO2 and how it fits in our treatment paradigm with N. Arvind Dasari.
Full Interview:
– On Targeted Oncology,
– On OncBrothers,
– Also on the ‘Oncology Brothers’ podcast.”
View the attached video.
Source: Rahul Gosain/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 14, 2024, 17:03
Oct 14, 2024, 16:54
Oct 14, 2024, 16:53
Oct 14, 2024, 16:51
Oct 14, 2024, 16:46
Oct 14, 2024, 16:28
Oct 14, 2024, 16:25